{"prompt": "['Confidential', 'Prof. Dr. Kristian Reich', 'Clinical Study Protocol', 'APLANTUS 069-008', 'Final 3.0, 07. June 2018', '14.10 Examination of Subgroups', '54', '14.11Sample Size Calculation', '54', '14.12Interim Analyses', '54', '14.13Multiple Comparison / Multiplicity', '54', '15 DATA HANDLING AND RECORD KEEPING', '55', '15.1 Data Collection', '55', '15.2 Source Documentation', '55', '15.3 Archiving', '56', '16 QUALITY CONTROL AND QUALITY ASSURANCE', '57', '16.1 Personnel Training', '57', '16.2 Clinical Monitoring', '57', '16.3 Audits / Inspections', '58', '17 ETHICS', '59', '17.1 Regulatory and Ethics Compliance', '59', '17.2 Informed Consent', '59', '17.3 Amendments to the Protocol', '60', '17.4 Confidentiality', '60', '18 FINANCING AND INSURANCE', '61', '18.1 Financing', '61', '18.2 Insurance', '61', '19 PUBLICATION POLICY', '62', '20 REFERENCES', '64', '21 APPENDICES', '67', '21.1 Appendix I - Dermatology Life Quality Index (DLQI)', '67', '21.2 Appendix Il - Psoriasis Area and Severity Index (PASI)', '69', '21.3 Appendix III: Palmoplantar Pustulosis Psoriasis Area and Severity Index (PPPASI)', '70', \"21.4 Appendix IV - Physician's Global Assessment (PGA)\", '72', '21.5 Appendix V - Dynamic Hand and Feet (H&F) PGA', '73', '21.6 Appendix VI - Hand and Feet (H&F) PGA', '74', '21.7 Appendix VII - Visual Analogue Scale (VAS)', '75', '2.1', 'List of Tables', 'Table 1: Pharmaceutical information', '32', 'Table 2: Dosing information', '32', 'Page 12 of 75']['Confidential', 'Prof. Dr. Kristian Reich', 'Clinical Study Protocol', 'APLANTUS 069-008', 'Final 3.0, 07. June 2018', '3', 'Contacts', 'Sponsor', 'Prof. Dr. Kristian Reich', 'Person(s) authorized to sign the protocol', 'TFS Trial Form Support GmbH (formerly', 'Prof. Dr. Kristian Reich', 'SClderm GmbH)', 'Drehbahn 1-3', '20354 Hamburg, Germany', 'CRO', 'TFS Trial Form Support GmbH', 'Monitoring (if other than the sponsor)', 'Juliane Kukla', 'Drehbahn 1-3', 'Tel', '+49 40 55 44 01 113', '20354 Hamburg, Germany', 'Fax', '+49 40 55 44 01 291', 'Email juliane.kukla@tfscro.com', 'Project Management', 'Dr. Thomas Bickert', 'Tel', '+49 40 55 44 01 182', 'Fax', '+49 40 55 44 01 291', 'Email thomas.bickert@tfscro.com', 'Statistics', 'Johanna Bewert', 'Tel', '+49 40 55 44 01 134', 'Fax:', '+494055 44 01 291', 'Email johanna.bewert@tfscro.com', 'Data Management', 'Franziska Laa\u00df', 'Tel', 'Fax', '+49405544 01 291', 'Email ranziska.laass@tfscro.com', 'Medical Writing', 'Dr. Wiebke Griemberg', 'Tel', '+49 40 5544 01129', 'Fax', '+4940 55 44 01291', 'Email wiebke.griemberg@tfscro.com', 'Quality Management', 'Tanja Henselmann', 'Tel', '+49405544 01 118', 'Fax', '+49 40 55 44 01 291', 'Email tanja.henselmann@tfscro.com', 'Page 13 of 75']['Confidential', 'Prof. Dr. Kristian Reich', 'Clinical Study Protocol', 'APLANTUS 069-008', 'Final 3.0, 07. June 2018', 'Coordinating Investigator', 'Dr. med Dagmar Wilsmann-Theis', 'Department for Dermatology and Allergy', 'University Bonn', 'Sigmund-Freud-Str. 25', '53105 Bonn, Germany', 'Tel', '+49 228 287 15370', 'Fax', '+49 228287 11176', 'Email dagmar.wilsmann-theis@ukb.uni-', 'bonn.de', 'Laboratory(ies) or medical / technical', 'departments', 'Serum / plasma immunological marker', 'Dr. med. Robert Sabat', 'analysis and skin biopsy immunological', 'Psoriasis Research and Treatment Center', 'marker analysis sub-study', '(PRTC),', 'Department of Dermatology and Allergy and', 'Institute of Medical Immunology', 'Charit\u00e9 - Universit\u00e4tsmedizin Berlin,', 'Charit\u00e9platz 1', '10117 Berlin, Germany', 'Tel', '+49 30 4505 18 625', 'Fax', '+49 30 4505 18 9 964', 'Email robert.sabat@charite.de', 'Page 14 of 75']\n\n###\n\n", "completion": "END"}